Belpointe Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.68M | Sell |
3,780
-225
| -6% | -$100K | 0.07% | 233 |
|
|
2025
Q1 | $1.94M | Buy |
4,005
+2,784
| +228% | +$1.35M | 0.1% | 186 |
|
|
2024
Q4 | $605K | Sell |
1,221
-26
| -2% | -$12.9K | 0.04% | 466 |
|
|
2024
Q3 | $580K | Buy |
1,247
+145
| +13% | +$67.4K | 0.03% | 467 |
|
|
2024
Q2 | $517K | Buy |
1,102
+76
| +7% | +$35.6K | 0.04% | 449 |
|
|
2024
Q1 | $429K | Buy |
1,026
+297
| +41% | +$124K | 0.03% | 474 |
|
|
2023
Q4 | $297K | Buy |
729
+50
| +7% | +$20.3K | 0.03% | 524 |
|
|
2023
Q3 | $236K | Sell |
679
-240
| -26% | -$83.5K | 0.02% | 554 |
|
|
2023
Q2 | $323K | Sell |
919
-595
| -39% | -$209K | 0.03% | 423 |
|
|
2023
Q1 | $477K | Sell |
1,514
-3,351
| -69% | -$1.06M | 0.03% | 585 |
|
|
2022
Q4 | $1.4M | Sell |
4,865
-2,062
| -30% | -$595K | 0.08% | 242 |
|
|
2022
Q3 | $2.01M | Buy |
6,927
+1,593
| +30% | +$461K | 0.14% | 157 |
|
|
2022
Q2 | $1.5M | Sell |
5,334
-334
| -6% | -$94.2K | 0.1% | 215 |
|
|
2022
Q1 | $1.48M | Sell |
5,668
-310
| -5% | -$80.9K | 0.09% | 239 |
|
|
2021
Q4 | $1.29M | Buy |
5,978
+281
| +5% | +$60.7K | 0.08% | 252 |
|
|
2021
Q3 | $1.03M | Buy |
5,697
+258
| +5% | +$46.8K | 0.07% | 302 |
|
|
2021
Q2 | $1.1M | Buy |
5,439
+897
| +20% | +$181K | 0.08% | 272 |
|
|
2021
Q1 | $976K | Buy |
4,542
+3,449
| +316% | +$741K | 0.08% | 258 |
|
|
2020
Q4 | $258K | Buy |
1,093
+354
| +48% | +$83.6K | 0.02% | 620 |
|
|
2020
Q3 | $201K | Sell |
739
-1,259
| -63% | -$342K | 0.02% | 548 |
|
|
2020
Q2 | $580K | Buy |
1,998
+296
| +17% | +$85.9K | 0.08% | 269 |
|
|
2020
Q1 | $405K | Sell |
1,702
-1,164
| -41% | -$277K | 0.07% | 280 |
|
|
2019
Q4 | $628K | Buy |
+2,866
| New | +$628K | 0.08% | 276 |
|